跳至主要内容
临床试验/ACTRN12621000994886
ACTRN12621000994886招募中未知

Efficacy of a Mediterranean diet on hormonal, metabolic and body composition in overweight and obese women with Polycystic Ovary Syndrome

Dr Anthony Villani0 个研究点目标入组 42 人开始时间: 2021年7月28日最近更新:

试验速览

阶段
未知
状态
招募中
发起方
入组人数
42

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 45 Years(—)
性别
Female

入选标准

  • 1. Confirmed diagnosis of Polycystic Ovary Syndrome according to the Rotterdam criteria which is based on participants presenting with two of the three following criteria including: 1) menstrual irregularity (infrequent menstrual periods) and/or anovulation; 2) clinical and/or biochemical hyperandrogenism; 3) polycystic ovaries based on ultrasound examination.
  • 2. Body mass index of 25kg/m2 or more

排除标准

  • Participants will be excluded based on the following criteria:
  • Type 2 diabetes
  • Current use of hormonal contraceptives or insulin sensitizing drugs
  • High adherence to a MedDiet defined as a score >10 using the 14-item Mediterranean diet adherence screener (MEDAS)
  • Cushing's syndrome
  • Hypothyroidism
  • Androgen tumors
  • Active cancer

研究者

发起方
Dr Anthony Villani

相似试验